Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Vincristine-induced abnormalities of gastrointestinal regulatory peptide cells of the rat

An immunocytochemical study

  • 48 Accesses

  • 12 Citations

Summary

The microtubule-disrupting drug vincristine is a common component of anti-cancer chemotherapeutic regimes, which produces acute constipation as a side effect. Although generally attributed to damage to the myenteric plexus, the precise mechanism of this disturbance is unknown. In addition, vincristine causes marked aberrations in the secretory response of pancreatic endocrine tissue in both man and rats. No information is available on its possible effect on regulatory peptides of the gastrointestinal tract. In this study we have produced vincristine-induced constipation in rats at a dosage comparable with that employed in the treatment of human subjects. Immunocytochemistry revealed concomitant disturbances in cells exhibiting immunoreactivity for gastrin in the antrum, for gastric inhibitory polypeptide and 5-hydroxytryptamine in the duodenum, for enteroglucagon in the colon, and for somatostatin in all three sites. These widespread effects are transient in nature with normal cell numbers and morphology being reestablished within 6 days. It is suggested that the observed effects are a direct result of microtubule disruption and that gastrointestinal regulatory peptide and amine immunoreactive cells have a rapid regeneration potential.

This is a preview of subscription content, log in to check access.

References

  1. Assan R, Soufflet E, Ballerio G, Attali JR, Boillot J, Girard JR (1978) Ambiguous effects of colchicine and vincristine upon A2-cell response to arginine. Diabetologia 14:121–127

  2. Beer CT, Richards JF (1964) The metabolism of vinca alkaloids. Part II. The fate of tritiated vinblastine in rats. Lloydia 27:352–360

  3. Buchanan KD (1979) Clinics in endocrinology and metabolism. Gastrointestinal hormones. WB Saunders Co Ltd, London

  4. Caviezel F, Poli M, Pozza G (1977) Effect of vincristine on glucose induced insulin secretion in man. Experientia 33:970–971

  5. Coons AH, Leduc EH, Connolly J (1955) Studies on antibody production. I. A method for the histochemical demonstration of specific antibody and its application to a study of the hyperimmune rabbit. J Exp Med 102:49–60

  6. Devis G, Van Obberghen E, Somers G, Malaisse-Lagae F, Orci L, Malaisse WJ (1974) Dynamics of insulin release and microtubular-microfilamentous system II. Effect of vincristine. Diabetologia 10:53–59

  7. Greenwald ES (1967) Cancer chemotherapy. Medical Examination Publishing Co., Inc., Flushing, New York

  8. Harris AC, Jackson JM (1977) Lactulose in vincristine-induced constipation. Med J Aust 2:573–574

  9. Launay JF, Stock C, Grenier JF (1979) Interaction of vinblastine with the secretagogue action of db-cAMP in the rat exocrine pancreas. Exp Cell Res 118:171–180

  10. Leclereg-Meyer V, Marchand J, Malaisse WJ (1974) Possible role of a microtubular-microfilamentous system in glucagon secretion. Diabetologia 10:215–224

  11. Long RG, Bishop AE, Barnes AJ, Albuquerque RH, O'Shaughnessy DJ, Bannister R, Polak JM, Bloom SR (1980) Neural and hormonal peptides in rectal biopsy specimens from patients with Chagas' disease and chronic autonomic failure. Lancet 1:559–562

  12. Shah JH, Udomphonkul N, Edwards G, Hurks C (1979) The diphasic effect of vincristine on glucose-induced insulin secretion and glucose tolerance in the intact rat. Endocrinology 105:1041–1047

  13. Shah JH, Stevens B, Sorensen BJ (1981) Dissociation of the effects of vincristine on stimulated insulin release and the pancreatic B-cell microtubular structures in the intact rat. Diabetes 30:539–544

  14. Smith B (1967) The myenteric plexus in drug-induced neuropathy. J Neurol Neurosurg Psychiatry 30:506–510

  15. Smith B (1972) The neuropathology of the alimentary tract. Edward Arnold, London

  16. Stevens FM, Shaw C (1982) Prolactin-like immunoreactivity in human small-intestinal mucosa. Br Med J 284:1014–1016

Download references

Author information

Correspondence to Dr. C. F. Johnston.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Johnston, C.F., Shaw, C. & Buchanan, K.D. Vincristine-induced abnormalities of gastrointestinal regulatory peptide cells of the rat. Cell Tissue Res. 239, 229–233 (1985). https://doi.org/10.1007/BF00214923

Download citation

Key words

  • Chemotherapy
  • Vincristine
  • Constipation
  • Mucosa
  • Regulatory peptides
  • Rat